Read + Share
Amedeo Smart
Independent Medical Education
Blonde L, Rosenstock J, Frias J, Birkenfeld AL, et al. Durable Effects of iGlarLixi Up to 52 Weeks in Type 2 Diabetes: The LixiLan-G Extension Study. Diabetes Care 2021 Jan 19. pii: dc20-2023. doi: 10.2337/dc20-2023.PMID: 33468520
Email
LinkedIn
Facebook
Twitter
Privacy Policy